The BioData World Congress USA is the world's leading event for leaders working in Big Data, genomics and precision medicine.
The meeting follows on from the huge success of the inaugural EU congress held in support and partnership of: The Wellcome Trust Sanger Institute, EMBL-EBI, Global Alliance for Genomics and Health, Babraham Institute, ABPI, Pharmacogenetics and Stratified Medicine Network, BIA, Pistoia Alliance and recently, Cancer Research UK and the Farr Institute.
Health care is joining the big-data club. With the advent of high-throughput genomics, life scientists are starting to grapple with massive data sets, encountering challenges with handling, processing and moving information that were once the domain of astronomers and high-energy physicists.
With the advent of revolutionary high-powered computing architecture and the exponential decrease in the cost of sequencing, this new era has now truly begun with the likes of Obama’s Precision Medicine Initiative® (PMI) taking centre stage in the efforts to drive the benefits of genomics into the clinic.
However, with the vast quantity of personal data there come challenges and questions into how to implement infrastructure and deliver this data in a usable format. Welcoming in this new generation of healthcare is a multifaceted effort requiring academics, commercial businesses, clinicians and pharmaceutical companies and of course the patients to congress and discuss how to develop this new exciting field of healthcare.
We have partnered with the worlds leading organizations to prepare for this. The BioData World Congress USA will showcase innovation, demonstrate success and break through the barriers to ensure that the innovations in genomics and big data enter the clinic with speed and efficiency. Join us in Boston to help make the dream of precision medicine a reality.